Bottle Label 800mg (67544 656)
Renagel
Product Images NDC 67544-656
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Renagel (NDC 67544-656). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Aphena Pharma Solutions (TN)
Figure 1. Chemical Structure Of Sevelamer Hydrochloride (Renagel Figure 1)
Figure 2. Percentage Of Patients (y-axis) Attaining A Phosphorus Reduction From Baseline (mg/dl) At Least As Great As The Value Of The X-axis. (Renagel Figure 2)
This is a graph showing the percentage of patients who experienced improvement or reduction after taking Sevelamer Hydrochloride and the extent of their reduction from the baseline in serum phosphorus levels. The graph illustrates the percentage of patients with a reduction greater than X in serum phosphorus levels. The X value is not shown in the graph.*
Figure 3. Mean Phosphorus Change From Baseline For Patients Who Completed 52 Weeks Of Treatment (Renagel Figure 3)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
